On multivariable analysis, an Na/K ratio above 3.96 was independently and significantly associated with a 7.3-fold increased odds for OAB. An elevated urinary sodium/potassium (Na/K) ratio is an ...

Jason Whiting, with more than 25 years' experience in medical technology, steps in as CEO of Avation Medical Inc., succeeding co-founder Jill Schiaparelli after six years. A Columbus startup ...

The concept involves a reservoir that can be easily inserted into the bladder and filled with the desired drug. The reservoir size must be balanced so that it is not too small to be voided out ...

“Sacral and Implantable Tibial Neuromodulation for the Management of Overactive Bladder: A Systematic Review ... may help avoid the long-term use of drug therapy that often leads to patient ...

A new study suggests that more women are being prescribed beta-3 agonists over anticholinergics for the treatment of overactive bladder (OAB ... prescriptions for OAB medications at two large ...

It offers inpatient, outpatient and residential day treatment for alcohol and drug addiction and has 100 inpatient beds available on their site. In 2014, the Betty Ford Center merged with Hazelden ...

Botox (onabotulinumtoxinA) is a brand-name drug that’s prescribed for various conditions, including overactive bladder and excessive sweating, in adults and some children. Botox comes as an ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window "We don't have an obvious fix for overactive bladder. But, while we still lack the knowledge about immunomodulation at ...

Patients with advanced bladder cancer that has spread to other parts of the body (metastasized) have responded well in a phase I clinical trial of an investigational drug, TYRA-300.

Patients with advanced bladder cancer that had spread to other parts of the body (metastasized) have responded well in a phase I clinical trial of an investigational drug, TYRA-300. The drug ...

Barcelona, Spain: Patients with advanced bladder cancer that had spread to other parts of the body (metastasised) have responded well in a phase I clinical trial of an investigational drug ...